Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD
Clinical trial NCT04269850 · TERMINATED
Trial details
- NCT number
- NCT04269850
- Sponsor
- St. Petersburg State Pavlov Medical University
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2024-11-27
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.